Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis.
Saved in:
| Title: | Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis. |
|---|---|
| Authors: | Falconi, Giulia1 (AUTHOR), Galossi, Elisa1 (AUTHOR), Fabiani, Emiliano1,2 (AUTHOR), Pieraccioli, Marco3 (AUTHOR), Travaglini, Serena1 (AUTHOR), Hajrullaj, Hajro1 (AUTHOR), Cerretti, Raffaella1 (AUTHOR), Palmieri, Raffaele1 (AUTHOR), Latagliata, Roberto4 (AUTHOR), Maurillo, Luca1 (AUTHOR), Voso, Maria Teresa1 (AUTHOR) voso@med.uniroma2.it |
| Source: | Scientific Reports. 12/8/2022, Vol. 12 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20452322 |
|---|---|
| DOI: | 10.1038/s41598-022-24644-1 |
